Kinaxis’ (KXS) Outperform Rating Reiterated at BMO Capital Markets

Kinaxis Inc (TSE:KXS)‘s stock had its “outperform” rating reiterated by stock analysts at BMO Capital Markets in a research note issued to investors on Monday. They presently have a C$74.00 price target on the stock. BMO Capital Markets’ price target suggests a potential upside of 10.90% from the company’s current price.

Several other research analysts have also commented on KXS. Laurentian lifted their target price on Kinaxis from C$70.00 to C$75.00 in a research report on Monday. Canaccord Genuity lifted their target price on Kinaxis from C$52.00 to C$70.00 and gave the stock a “buy” rating in a research report on Saturday, August 6th. RBC Capital Markets lifted their target price on Kinaxis from C$68.00 to C$72.00 in a research report on Saturday, August 6th. CIBC lifted their target price on Kinaxis from C$52.00 to C$75.00 in a research report on Saturday, August 6th. Finally, National Bank Financial reiterated an “outperform overweight” rating on shares of Kinaxis in a research report on Monday, September 26th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Kinaxis currently has an average rating of “Buy” and a consensus target price of C$68.73.

Kinaxis (TSE:KXS) traded down 1.35% on Monday, reaching $65.28. The company’s stock had a trading volume of 37,839 shares. The firm has a market capitalization of $1.61 billion and a P/E ratio of 141.61. The firm has a 50-day moving average price of $63.77 and a 200 day moving average price of $54.06. Kinaxis has a 52-week low of $32.60 and a 52-week high of $69.85.